Cost Per-Responder Analysis of Secukinumab Compared To Adalimumab For The Treatmenmt of Ankylosing Spondylitis Over One Year In Saudi Arabia
Abstract
Authors
H Al Mudaiheem M Al Howimel K Al Jufan H Al Hamdan A AlAlwan N Alshehri N Zakaria L Al Kateb G Ramakrishna